share_log

Needham Reiterates Buy on Verrica Pharmaceuticals, Maintains $16 Price Target

Needham Reiterates Buy on Verrica Pharmaceuticals, Maintains $16 Price Target

Needham重申买入Verrica Pharmicals,维持16美元的目标股价
Benzinga ·  05/16 11:41

Needham analyst Serge Belanger reiterates Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy and maintains $16 price target.

尼德姆分析师塞尔吉·贝兰格重申维里卡制药公司(纳斯达克股票代码:VRCA)的买入并维持16美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发